NCT02178163View on ClinicalTrials.gov

Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer

NARecruitingINTERVENTIONAL
Enrollment

1,020

Participants

Timeline

Start Date

August 1, 2014

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Recurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Interventions
OTHER

cytology specimen collection procedure

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (11)

48043

RECRUITING

KCI at McLaren Macomb, Mount Clemens

48060

RECRUITING

KCI at McLaren Port Huron, Port Huron

48201

RECRUITING

Barbara Ann Karmanos Cancer Institute, Detroit

48302

RECRUITING

KCI at Mclaren Bloomfield Hills, Bloomfield Hills

48346

RECRUITING

KCI At McLaren Clarkston, Clarkston

48446

RECRUITING

KCI at McLaren Lapeer Region, Lapeer

48532

RECRUITING

KCI at McLaren Flint, Flint

48708

RECRUITING

KCI at McLaren Bay Region, Bay City

48858

RECRUITING

KCI at McLaren Central Michigan, Mount Pleasant

48910

RECRUITING

KCI at McLaren Greater Lansing, Mid Michigan Physicians, Lansing

49770

RECRUITING

KCI at Northern Michigan, Petoskey

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER